Cliff Asness's ADMA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.53 M shares of ADMA Biologics, Inc. (ADMA) worth $12.77 M, representing 0.00% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ADMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 1.01 M shares. Largest reduction occurred in Q3 2025, reducing 184,722 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's ADMA Biologics (ADMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADMA Biologics (ADMA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1.01 M | Add 196.35% | 1.53 M | $8.37 |
| Q1 2026 | +208,582 | Add 68.12% | 514,789 | $9.01 |
| Q4 2025 | +31,048 | Add 11.28% | 306,207 | $18.24 |
| Q3 2025 | -184,722 | Reduce 40.17% | 275,159 | $14.66 |
| Q2 2025 | -60,007 | Reduce 11.54% | 459,881 | $18.21 |
| Q1 2025 | -10,280 | Reduce 1.94% | 519,888 | $19.84 |
| Q4 2024 | -59,145 | Reduce 10.04% | 530,168 | $17.15 |
| Q3 2024 | -184,093 | Reduce 23.80% | 589,313 | $19.99 |
| Q2 2024 | -43,547 | Reduce 5.33% | 773,406 | $11.18 |
| Q1 2024 | +225,750 | Add 38.18% | 816,953 | $6.60 |
| Q4 2023 | +49,160 | Add 9.07% | 591,203 | $4.52 |
| Q3 2023 | +90,236 | Add 19.97% | 542,043 | $3.58 |
| Q2 2023 | +312,493 | Add 224.31% | 451,807 | $3.69 |
| Q1 2023 | +16,463 | Add 13.40% | 139,314 | $3.31 |
| Q4 2022 | +48,655 | Add 65.58% | 122,851 | $3.88 |
| Q3 2022 | +74,196 | New Buy | 74,196 | $2.43 |
| Q3 2020 | -29,215 | Sold Out | 0 | $0.00 |
| Q2 2020 | +29,215 | New Buy | 29,215 | $2.94 |
Cliff Asness's ADMA Biologics Investment FAQs
Cliff Asness first purchased ADMA Biologics, Inc. (ADMA) in Q2 2020, acquiring 29,215 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held ADMA Biologics, Inc. (ADMA) for 18 quarters since Q2 2020.
Cliff Asness's largest addition to ADMA Biologics, Inc. (ADMA) was in Q2 2026, adding 1,525,581 shares worth $12.77 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,525,581 shares of ADMA Biologics, Inc. (ADMA), valued at approximately $12.77 M.
As of the Q2 2026 filing, ADMA Biologics, Inc. (ADMA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in ADMA Biologics, Inc. (ADMA) was 1,525,581 shares, as reported at the end of Q2 2026.